GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (CHIX:MOVEz) » Definitions » YoY EBITDA Growth

Medacta Group (CHIX:MOVEZ) YoY EBITDA Growth : 51.05% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Medacta Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Medacta Group's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 51.05%.

Medacta Group's EBITDA per Share for the six months ended in Dec. 2024 was CHF3.52.

Medacta Group YoY EBITDA Growth Historical Data

The historical data trend for Medacta Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group YoY EBITDA Growth Chart

Medacta Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 56.12 19.06 4.95 7.59 29.22

Medacta Group Semi-Annual Data
Dec15 Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.38 15.81 -3.28 14.15 51.05

Medacta Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Medacta Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(7.51-5.812)/ | 5.812 |
=29.22 %

Medacta Group's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(3.518-2.329)/ | 2.329 |
=51.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medacta Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Medacta Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Medacta Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (CHIX:MOVEz) » Definitions » YoY EBITDA Growth
Comparable Companies
XSWX:MED XSWX:KURN ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM STE PODD XAMS:PHIA XSWX:SOON ZBH SHSE:688271 TSE:7733 LSE:SN. ASX:COH TSE:6869
Traded in Other Exchanges
0A05:UK 6MD:Germany MOVE:Switzerland
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Website
https://www.medacta.com
Medacta Group SA is involved in developing, manufacturing and distributing orthopedic and neurosurgical medical devices. The company offers solutions for Hip, Knee, Shoulder and Spine. The majority of the company's revenue is generated from Europe, Middle East, and Africa (EMEA) and the rest from other regions.

Medacta Group Headlines

No Headlines